Phase 1 Respiratory Infection Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Cystic Fibrosis LungRespiratory Infections, Recurrent, Chronic

Respirion Pharmaceuticals Pty Ltd72 enrolled22 locationsNCT06016088

Recruiting

Phase 1

Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers

InfluenzaViral Respiratory Infection

Valenta Pharm JSC36 enrolled1 locationNCT06859333